10-KPeriod: FY2009

Cencora, Inc. Annual Report, Year Ended Sep 30, 2009

Filed November 25, 2009For Securities:COR

Summary

Cencora, Inc. (COR) filed its 2009 10-K on November 24, 2009, detailing its business operations and financial performance for the fiscal year ending September 29, 2009. As a healthcare company, Cencora's business is largely dependent on its ability to effectively manage its supply chain and distribution networks for pharmaceutical and other healthcare products. Investors should pay close attention to the company's revenue streams, profitability drivers, and any potential risks that could impact its operations, such as regulatory changes, competition, and the evolving healthcare landscape. The filing provides a comprehensive overview of the company's strategic initiatives, operational efficiency, and financial health. Key areas to scrutinize include the Management's Discussion and Analysis (MD&A) section, which offers management's perspective on the company's performance and outlook. Investors should also review the Risk Factors section for potential headwinds and the Financial Statements for a thorough understanding of the company's assets, liabilities, and cash flows. The report lays the groundwork for understanding Cencora's position in the market and its prospects for future growth.

Financial Highlights

56 data points
Beta

Revenue

$71.76B

2.9% Gross Margin

Net Income

$503.40M

0.7% Net Margin

EPS (Diluted)

$1.66

Total Assets

$13.57B

Cash & Equivalents

$1.01B

Free Cash Flow

$637.93M

Financial Statements
Beta
Revenue$71.76B
Cost of Revenue$69.66B
Gross Profit$2.10B
SG&A Expenses$1.12B
Operating Income$883.75M
Net Income$503.40M
EPS (Basic)$1.67
EPS (Diluted)$1.66
Shares Outstanding (Basic)300.57M
Shares Outstanding (Diluted)302.75M

Key Highlights

  • 1The 10-K report covers the fiscal year ending September 29, 2009, providing a year-end financial and operational overview.
  • 2The filing includes standard sections such as Business Description, Risk Factors, Properties, Legal Proceedings, and Executive Officers.
  • 3Key financial information and analysis are found in the Selected Financial Data and Management's Discussion and Analysis (MD&A) sections.
  • 4The report details the Market for Registrant's Common Equity and related stockholder matters.
  • 5Audited Financial Statements and Supplementary Data are presented, offering a deep dive into the company's financial position.
  • 6Disclosures regarding Controls and Procedures (9A) and Principal Accountant Fees and Services (14) are included for investor diligence.
  • 7Information on Directors, Executive Officers, Corporate Governance, Executive Compensation, and Security Ownership is provided in Part III.

Frequently Asked Questions

The provided excerpt of the 10-K filing outlines the structure of the report but does not contain specific details on Cencora's business segments or revenue drivers for fiscal year 2009. Investors would need to refer to Part I, Item 1 (Business) and Part II, Item 7 (Management's Discussion and Analysis of Financial Condition and Results of Operations) of the full 10-K filing for this information.

The excerpt indicates that 'Risk Factors' are detailed in Part I, Item 1A. While the specific risks are not listed here, typical risks for a company like Cencora in the healthcare distribution sector could include regulatory changes, competition, supply chain disruptions, economic downturns, and changes in customer demand or reimbursement policies. Investors should consult the full filing for the precise risks identified by management.

Key financial performance metrics for fiscal year 2009 can be found in Part II, Item 6 (Selected Financial Data) and Part II, Item 7 (Management's Discussion and Analysis of Financial Condition and Results of Operations) of the 10-K filing. The Financial Statements and Supplementary Data in Item 8 will provide the most detailed breakdown of the company's financial position, including revenue, expenses, net income, and cash flows.

Information regarding executive compensation, directors, executive officers, and corporate governance is detailed in Part III of the 10-K filing, specifically in Items 10 (Directors, Executive Officers and Corporate Governance), 11 (Executive Compensation), and 12 (Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters).